Welcome to our dedicated page for Curtiss Wright SEC filings (Ticker: CW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Curtiss-Wright Corporation filings document financial results, governance matters and capital actions for an operating company serving Aerospace & Defense, commercial nuclear power, process and industrial markets. Recent Form 8-K reports furnish quarterly and annual results releases, webcast presentations and outlook commentary tied to the company’s operating markets.
Proxy materials and annual-meeting reports cover director elections, independent auditor ratification and advisory executive-compensation votes. Other Form 8-K disclosures describe common-stock repurchase authorizations, Rule 10b5-1 trading plans, potential repurchase methods and related risk language under the Exchange Act.
Farkas K Christopher reported acquisition or exercise transactions in this Form 4 filing.
Curtiss-Wright Executive VP and CFO K. Christopher Farkas received a grant of 645 restricted stock units (RSUs) on March 9, 2026. These RSUs were granted as an employee benefit under the company’s 2024 Omnibus Incentive Plan and carry no purchase price.
Each RSU represents a contingent right to receive one share of Curtiss-Wright common stock, with the award cliff vesting after a three-year period from the grant date. Following this grant, Farkas holds 11,549 RSUs in total, a figure that also reflects dividend credits earned on prior outstanding grants.
Bamford Lynn M reported acquisition or exercise transactions in this Form 4 filing.
Curtiss-Wright Corp reported that Chair and CEO Lynn M. Bamford received a grant of 2,735 time-based restricted stock units (RSUs) under the company’s 2024 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of common stock.
The RSUs will cliff vest after a three-year vesting period from the March 9, 2026 grant date, aligning the award with longer-term performance. The grant was made as an employee benefit with no cash price on the grant date. Following this award, Bamford directly holds 22,281 shares and RSUs, a figure that includes dividend credits earned on prior grants.
Curtiss-Wright Corporation’s Executive VP and CFO, K. Christopher Farkas, reported an open-market sale of 3,105 shares of common stock at an average price of $694.51 per share. The sale was executed under a pre-arranged Rule 10b5-1 trading plan and in line with company share ownership guidelines. Following this transaction, he directly holds 4,253 shares of Curtiss-Wright common stock.
The issuer filed a Form 144 disclosing proposed sales of Common stock totaling 3,105 shares tied to a performance share vesting event dated 02/03/2026, with UBS Financial Services Inc. listed as broker. The filing also reports prior dispositions by K. Christopher Farkas: 5,047 shares on 11/11/2025 for $2,916,721.36 and 2,665 shares on 02/04/2026 for $1,669,034.61.
Curtiss-Wright Corporation filed its annual report describing a diversified, engineering-focused portfolio serving aerospace, defense, naval, nuclear power, and industrial markets. The company operates through three segments: Aerospace & Industrial, Defense Electronics, and Naval & Power, with a growing emphasis on its Pivot to Growth strategy.
Government-related business is a key driver: sales to the U.S. Government and foreign government end use represented 58% of 2025 total net sales, with U.S. Government sales of $1,647,019,000. Backlog was about $4.1 billion, supporting future revenue visibility. Foreign operations contributed 41% of pre-tax earnings in 2025, and about 27% of total net sales came from customers outside the U.S.
The company ended 2025 with roughly 9,100 employees in more than 20 countries and emphasizes culture, safety, and talent development. Safety metrics improved modestly, with TRR of 1.22 and DART of 0.71. Curtiss-Wright also highlights key risks, including heavy defense exposure, complex government regulations, cybersecurity threats, acquisition execution, climate and ESG pressures, and financial risks tied to $2.2 billion of goodwill and about $1.0 billion of debt.
Curtiss-Wright reported record fourth-quarter and full-year 2025 results with strong growth in sales, earnings, and cash flow. For Q4 2025, sales were $947 million, up 15%, and adjusted diluted EPS was $3.79, up 16%. Full-year 2025 sales reached $3.5 billion, up 12%, with adjusted operating income of $651 million, up 19%, and adjusted EPS of $13.23, up 21%. Free cash flow was $554 million, a 15% increase with 111% conversion, while new orders of $4.1 billion and backlog of $4.1 billion each rose 10% and 18%, respectively. The company repurchased $465 million of stock. For 2026, Curtiss-Wright guides to 6%–8% sales growth, adjusted operating margin of 18.9%–19.2%, adjusted EPS of $14.70–$15.15 (up 11%–15%), and free cash flow of $575–$595 million.
Curtiss-Wright director Anthony J. Moraco received an annual equity award of 256 shares of common stock on February 4, 2026. The shares were granted under the company’s 2024 Omnibus Incentive Plan as restricted stock for his service on the board.
The award value was $160,000, calculated using the closing share price of $624.93 on the grant date and rounded down to the nearest whole share. Restrictions lapse after one year or earlier if his board service ends due to death, disability, or failure to be reelected. Following this grant, Moraco directly holds 5,446 shares of Curtiss-Wright common stock.
Curtiss-Wright Corporation director Larry D. Wyche reported an equity grant of restricted common stock. On February 4, 2026, he acquired 128 shares of common stock at a reference price of $624.93 per share under the company’s 2024 Omnibus Incentive Plan.
The award represents half of a $160,000 annual restricted stock grant for non-employee directors, with the number of shares determined by dividing the grant value by the closing price and rounding down. Wyche elected to defer receipt of the remaining 128 shares to a later date. Following this transaction, he beneficially owned 1,514 common shares directly. Restrictions on the granted shares generally lapse after one year or earlier upon death, disability, or failure to be reelected.
Curtiss-Wright executive John C. Watts reported routine share transactions in company stock. On February 3, 2026, he acquired 1,354 shares of common stock through a performance share grant under the 2014 Long Term Incentive Plan, based on three-year total shareholder return versus a peer group.
On February 4, 2026, Watts sold 652 shares of common stock at an average price of $625.57 per share, in line with company share ownership guidelines that allow sales to cover individual income tax obligations from vesting. After these transactions, he directly owned 3,890 Curtiss-Wright common shares.
Curtiss-Wright senior vice president and treasurer Robert F. Freda reported an equity award vesting and a related share sale. On February 3, 2026, he acquired 784 shares of common stock through a performance share grant under the 2014 Long Term Incentive Plan, based on three-year total shareholder return versus a peer group, at a reference price of $674.32 per share.
On February 4, 2026, Freda sold 418 shares of common stock at an average price of $626.95, with individual trades ranging from $611.26 to $658.97. The sale was conducted under company share ownership guidelines to cover income tax obligations from the vesting. After these transactions, he directly held 5,187 shares of Curtiss-Wright common stock.